These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29569003)

  • 21. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis.
    Park SW; Um SH; Lee HA; Kim SH; Sim Y; Yim SY; Seo YS; Ryu HS
    Clin Mol Hepatol; 2016 Jun; 22(2):281-5. PubMed ID: 27246353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term results of mycophenolate mofetil
    Dalekos GN; Arvaniti P; Gatselis NK; Gabeta S; Samakidou A; Giannoulis G; Rigopoulou E; Koukoulis GK; Zachou K
    JHEP Rep; 2022 Dec; 4(12):100601. PubMed ID: 36411768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis.
    Yu ZJ; Zhang LL; Huang TT; Zhu JS; He ZB
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):873-877. PubMed ID: 31150366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Withdrawal of steroids: a randomized prospective study of prednisone and tacrolimus versus mycophenolate mofetil and tacrolimus in liver transplant recipients with autoimmune hepatitis.
    Junge G; Neuhaus R; Schewior L; Klupp J; Guckelberger O; Langrehr JM; Tullius S; Neuhaus P
    Transplant Proc; 2005 May; 37(4):1695-6. PubMed ID: 15919434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
    Richardson PD; James PD; Ryder SD
    J Hepatol; 2000 Sep; 33(3):371-5. PubMed ID: 11019991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A; Gupta A; Kalaivani M; Hari P; Dinda AK; Bagga A
    Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of mycophenolate mofetil for the treatment of autoimmune hepatitis-an observational study.
    Jothimani D; Cramp ME; Cross TJ
    J Clin Exp Hepatol; 2014 Sep; 4(3):221-5. PubMed ID: 25755564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune hepatitis: Current and future therapeutic options.
    Doycheva I; Watt KD; Gulamhusein AF
    Liver Int; 2019 Jun; 39(6):1002-1013. PubMed ID: 30716203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.
    Langrehr JM; Klupp J; Glanemann M; Junge G; Pfitzmann R; Bahra M; Radtke C; Neumann U; Neuhaus R; Neuhaus P
    Clin Transplant; 2006; 20(3):272-83. PubMed ID: 16824141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy.
    Than NN; Wiegard C; Weiler-Normann C; Füssel K; Mann J; Hodson J; Hirschfield GM; Lohse AW; Adams DH; Schramm C; Oo YH
    Scand J Gastroenterol; 2016 Mar; 51(3):329-36. PubMed ID: 26458216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
    Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
    Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Second-line therapy with mycophenolate mofetil in patients with autoimmune hepatitis who were intolerant or failed to respond to standard treatment].
    Miura R; Yagi M; Matsumoto K; Miki A; Isono A; Aoyagi H; Abe K; Tachizawa N; Arizumi T; Aiso M; Kodashima S; Asaoka Y; Yamamoto T; Tanaka A
    Nihon Shokakibyo Gakkai Zasshi; 2021; 118(4):318-326. PubMed ID: 33840713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mycophenolate mofetil in treatment of graft-versus-host disease after allogeneic hematopoietic cell transplantation: analysis of 44 cases].
    Chen H; Liu KY; Liu DH; Xu LP; Han W; Chen YH; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2127-30. PubMed ID: 19080474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.
    Snijders RJALM; Stoelinga AEC; Gevers TJG; Pape S; Biewenga M; Verdonk RC; de Jonge HJM; Vrolijk JM; Bakker SF; Vanwolleghem T; de Boer YS; Pronk MAMCB; Beuers UHW; van der Meer AJ; van Gerven NMF; Sijtsma MGM; Verwer BJ; Gisbertz IAM; Bartelink M; van den Brand FF; Sebib Korkmaz K; van den Berg AP; Guichelaar MMJ; Soufidi K; Levens AD; van Hoek B; Drenth JPH;
    Trials; 2022 Dec; 23(1):1012. PubMed ID: 36514163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up of children and young adults with autoimmune hepatitis treated with cyclosporine.
    Nastasio S; Sciveres M; Matarazzo L; Malaventura C; Cirillo F; Riva S; Maggiore G
    Dig Liver Dis; 2019 May; 51(5):712-718. PubMed ID: 30502231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
    Li X; Ren H; Zhang Q; Zhang W; Wu X; Xu Y; Shen P; Chen N
    Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.
    Bhatia M; Militano O; Jin Z; Figurski M; Shaw L; Moore V; Morris E; Tallamy B; van deVen C; Ayello J; Baxter-Lowe L; Satwani P; George D; Bradley MB; Garvin J; Cairo MS
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):333-43. PubMed ID: 19835971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.